Skip to content
Search

Latest Stories

PSNC disappointed as CPCF annual review ends without funding boost

The Pharmaceutical Services Negotiating Committee (PSNC) has expressed disappointment as the government continued to refuse to “a much-needed broader funding uplift” for the community pharmacies in England.

This follows conclusion of the first Annual Review of the progress of the five-year Community Pharmacy Contractual Framework (CPCF) deal by PSNC, the Department of Health and Social Care (DHSC) and NHS England & NHS Improvement (NHSE&I).


“We remain deeply frustrated by government’s refusal to agree a much-needed broader funding uplift for the sector, but we are determined to continue to look for better ways forward for the sector throughout 2022 and beyond,” said Bharat Patel, PSNC vice-chair, negotiating team member and an independent contractor.

Patel noted that despite some important wins such as recognition of key challenges faced by pharmacies, the commitment to consider these as part of our Year 4 negotiations, and agreement to take forward work on service fee and other regulatory changes, the PSNC is disappointed that the review did not lead to “immediate and tangible outcomes and improvements for contractors.”

The negotiator had put forward data and analysis showing the capacity and cost constraints faced by pharmacies.

Mike Dent, PSNC director of Pharmacy Funding, said: “Our data also provides useful evidence to support ongoing discussions about the extraordinary performance and value of pharmacies”.

“PSNC is now working to build on the outputs of the review in the upcoming Year 4 negotiations: we will be gathering and analysing more data to support our discussions, as well as continuing to highlight the pressures on the sector, and exploring ways to bid again for additional funding over the course of this year.”

Tricia Kennerley, PSNC negotiating team member and VP, director International Public Affairs at Walgreens Boots Alliance, said that situation for contractors continues to worsen.

She added that PSNC has clearly stated “the immense pressures the sector is facing”, which is important ahead of “another critical round of discussions for the sector, with many contractors simply unable to take on any further services without additional funding, support and access to the right staff.”

Reacting to the review outcome, the National Pharmacy Association chief executive Mark Lyonette said: “It appears this annual contract review has rubber-stamped another year of cuts for pharmacies across England.

“This is an insult to pharmacy teams, who have worked relentlessly hard to help keep the country on its feet during the Covid pandemic."

He added that high costs, increased public demand for pharmacy support have increased pressures and demotivated many staff.

“Instead of moving forwards into new clinical roles, which the NHS and DHSC say they want, pharmacies could now slip back, focus narrowly on dispensing and reduce access to care – the very opposite of the aspirations stated in the NHS Plan.

“Governments, NHS and negotiators elsewhere in the UK are working to agreed visions and decently funded strategies. England should follow suit and jettison the nonsense that great services can be provided on a shorter and shorter shoestring.”

Meanwhile, PSNC stated that all parties have agreed to:

  • Recognise the capacity constraints within the sector in the upcoming Year 4 negotiations;
  • Explore the scale and impact of the more complex consultations now taking place in community pharmacy – the Pharmacy Advice Audit begins this process;
  • Continue and conclude discussions on services fee setting principles; and
  • Consider measures for assessing capacity within community pharmacies.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less